logo
Shares of Indian brokers, BSE drop as regulator bars Jane Street

Shares of Indian brokers, BSE drop as regulator bars Jane Street

Reuters2 days ago
July 4 (Reuters) - Shares of some Indian stockbrokers and market intermediaries fell on Friday after the country's securities regulator barred U.S. trading firm Jane Street from the local market over alleged manipulation in derivatives trading.
The Securities and Exchange Board of India (SEBI), in an interim order dated July 3, stated that Jane Street, one of the world's largest quant trading firms, would no longer be able to participate in the domestic securities market.
The order is based on SEBI's initial investigation, and the ban will stay in place till a final order is issued after the completion of the investigation.
Jane Street, in an emailed response, disputed the findings of the SEBI interim order and said it will further engage with the regulator.
Angel One (ANGO.NS), opens new tab, one of India's top brokerage firms, slumped 6%. Stock exchange BSE (BSEL.NS), opens new tab was trading 6.4% lower and Central Depository Services (India) (CENA.NS), opens new tab fell 3.5%.
Nuvama Wealth Management (NUVA.NS), opens new tab, which is Jane Street's India trading partner, fell more than 9%. The company did not respond to a Reuters request for a comment.
Equity benchmarks Nifty 50 (.NSEI), opens new tab and BSE Sensex (.BSESN), opens new tab were trading flat on Friday afternoon.
Some analysts said the regulator's action could impact derivative volumes in the near term, which triggered a drop in the shares of market participants.
"We may see some nervousness or pain in the short term in terms of volumes. But market integrity is crucial from a longer-term perspective as it (the regulatory action) helps build confidence among traders," said UR Bhat, co-founder of Alphaniti Fintech.
Derivatives trading is booming in India, where participation of retail traders has skyrocketed.
In a study last year, SEBI said retail traders made net losses totalling $21.7 billion in futures and options trading in the three years to March 2024.
Most of the profits were generated by larger entities that used trading algorithms, with 97% of foreign investors' profits and 96% of proprietary traders' profits coming from algorithmic trading, SEBI said.
"We've already seen average premium turnover on the NSE and the BSE come down 17% and 13%, respectively, in June", when it became known that SEBI was investigating Jane Street, said Amit Chandra, vice president at HDFC Securities.
"What we are seeing now is a more realistic volume that we can expect and it will take some time for volumes to go up from here on," Chandra said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China retaliates against EU with a ban on European medical devices
China retaliates against EU with a ban on European medical devices

The Independent

timean hour ago

  • The Independent

China retaliates against EU with a ban on European medical devices

China said Sunday that European medical device companies will be barred from selling to the Chinese government as a countermeasure for the European Union's restrictions on the sale of similar products from China. European companies will be excluded if the budget for procurement is above 45 million yuan ($6.28 million), according to a notice from the Finance Ministry on Sunday with the restrictions in place the same day. The move will not apply to European companies that have invested in China and that manufacture goods in the country. China on Friday imposed anti-dumping duties on European brandy, most notably cognac produced in France. While the duties on brandy include several exceptions for major brandy producers, China and the EU have multiple trade disputes across a range of industries. China protested after many European countries levied duties on EVs made in China. Since then, China has also launched investigations into European pork and dairy products. In June, the EU announced that Chinese companies were to be excluded from any government purchases of more than 5 million euros ($5.89 million). The measure seeks to incentivise China to cease its discrimination against EU firms, the EU said, accusing China of erecting "significant and recurring legal and administrative barriers to its procurement market.' In response, China has said it had 'no choice but to implement countermeasures.' 'China has repeatedly expressed through bilateral dialogues that it is willing to properly handle differences with the EU through dialogue and consultation and bilateral government procurement arrangements,' said a statement from a spokesman with the Ministry of Commerce. 'Unfortunately, the EU has ignored China's goodwill and sincerity and still insisted on taking restrictive measures and building new protectionist barriers.'

Nissan considers Foxconn EV output to save Oppama from closure, Nikkei says
Nissan considers Foxconn EV output to save Oppama from closure, Nikkei says

Reuters

timean hour ago

  • Reuters

Nissan considers Foxconn EV output to save Oppama from closure, Nikkei says

TOKYO, July 6 (Reuters) - Nissan Motor (7201.T), opens new tab is in discussions with Taiwan's Foxconn ( opens new tab about a collaboration in electric vehicles that could save its Oppama plant in Japan from closure, the Nikkei business daily reported on Sunday, citing an unidentified Nissan source. Nissan's Oppama plant, which employs about 3,900 workers, has been a potential consolidation target in the struggling Japanese carmaker's restructuring plans, but the floated idea of producing Foxconn-brand EVs at its idle assembly lines could preserve the jobs and supplier networks, Nikkei said.

China restricts EU imports of medical devices
China restricts EU imports of medical devices

Reuters

time3 hours ago

  • Reuters

China restricts EU imports of medical devices

HONG KONG, July 6 (Reuters) - China's finance ministry said on Sunday it was restricting imports of medical devices from the European Union that exceed 45 million yuan ($6.3 million) in value. China will also restrict imports of medical devices from other countries that contain EU-made components worth more than 50% of the contract value, the finance ministry said. The measures come into force on Sunday. ($1 = 7.1645 Chinese yuan renminbi)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store